Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors-Reference-Cited by-同舟云学术

Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors

Published:2016-08-22 Issue:8 Volume:11 Page:e0159477
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Thokala Radhika^ORCID,Olivares Simon,Mi Tiejuan,Maiti Sourindra,Deniger Drew,Huls Helen,Torikai Hiroki,Singh Harjeet,Champlin Richard E.,Laskowski Tamara,McNamara George,Cooper Laurence J. N.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference71 articles.

1. Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells;LJ Eggermont;Trends in Biotechnology,2015

2. Adoptive cell transfer as personalized immunotherapy for human cancer;SA Rosenberg;Science,2015

3. Universes Collide: Combining Immunotherapy with Targeted Therapy for Cancer;JA Wargo;Cancer Discovery,2014

4. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors;Z Eshhar;Proc Natl Acad Sci U S A,1993

5. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells;CM Kowolik;Cancer Res,2006

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically Engineered CLDN18.2 CAR-T Cells Expressing Synthetic PD1/CD28 Fusion Receptors Produced Using a Lentiviral Vector;Journal of Microbiology;2024-05-03

2. Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia;Molecular Therapy - Oncolytics;2023-12

3. Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment;Journal of Experimental & Clinical Cancer Research;2023-10-06

4. FLT3‐directed UniCAR T‐cell therapy of acute myeloid leukaemia;British Journal of Haematology;2023-07-17

5. Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies;Biomarker Research;2023-07-04